Journals / European Journal of Therapeutics / 2018 / Cilt: 24 - Sayı: 4

Investigation of the Protective Effects of Nigella Sativa Oil and Thymoquinone in Radiation Exposed Rats

Pages
224–228
Publication Date
2022-10-12
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Further studies should be conducted to investigate different tissues, with different radiation intensitiesand different concentrations of Nigella sativa oil.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: It is not always possible to treat early and late side effects due to radiotherapy.
📊
Key Findings & Data:In this study, the effects of free radicalson the oxidant antioxidant system were investigated in comparison with the clinical use of WR-2721 in the prevention and treatmentof side effects caused by free radicals.Methods: According to the experimental protocol, rats were randomly assigned to five groups: Control Group (K; n=10), RadiotherapyGroup (R; n=10), Nigella sativa oil Group (NSO; n=10; 2.4 g/kg/day), Nigella sativa oil+Radiotherapy Group (R+NSO; n=10;60 min; 2.4 g/kg/day), Radiotherapy+Amifostine Group (R+WR-2721; n=10; 200 mg / kg / day; 60 min before 60 min.
💡
Conclusion & Impact:Further studies should be conducted to investigate different tissues, with different radiation intensitiesand different concentrations of Nigella sativa oil.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: It is not always possible to treat early and late side effects due to radiotherapy. In this study, the effects of free radicalson the oxidant antioxidant system were investigated in comparison with the clinical use of WR-2721 in the prevention and treatmentof side effects caused by free radicals.Methods: According to the experimental protocol, rats were randomly assigned to five groups: Control Group (K; n=10), RadiotherapyGroup (R; n=10), Nigella sativa oil Group (NSO; n=10; 2.4 g/kg/day), Nigella sativa oil+Radiotherapy Group (R+NSO; n=10;60 min; 2.4 g/kg/day), Radiotherapy+Amifostine Group (R+WR-2721; n=10; 200 mg / kg / day; 60 min before 60 min. Radiotherapywas applied to the rats using radioactive cobalt-60 teletherapy machine in a single dose of 8 Gy to the whole body area as SSD 40cm. The study was completed in 72 h following radiation application, and the rats were sacrificed by decapitation. Oxidative StressIndex (OSİ) Total Oxidative Stress (TOS) Total Antioxidant Status(TAS) malondialdehyde (MDA), nitric oxide (NO), myeloperoxidase(MPO), superoxide dismutase (SOD), glutathione (GSH), and catalase (CAT) parameters were measured.Results: According to these results, WR has more positive effects on MPO and CAT values when NSO on MDA values. There wasno statistically significant difference in TOS, OSI, NO, TAS, SOD, CAT values between the R + NSO and K Groups. Compared to the RGroup, TOS, OSI, NO, MDA levels significantly decreased and TAS, SOD, GSH, CAT levels significantly increased in the R+NSO Group.Conclusion: In this study, we have shown that Nigella sativa oil is effective in radiation-induced damage on the liver oxidativestress and nitrosative stress. Further studies should be conducted to investigate different tissues, with different radiation intensitiesand different concentrations of Nigella sativa oil.

🔖

Cite This Article

TARAKÇIOĞLU, M., DEMİREL, C., GÖZEN, H., AKAN, M. (2022). Investigation of the Protective Effects of Nigella Sativa Oil and Thymoquinone in Radiation Exposed Rats. European Journal of Therapeutics, Cilt: 24 - Sayı: 4, 224–228. https://ajindex.com/articles/512284

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Beyzadeoğlu M. Basic Radiation Oncology. Springer-Verlag Berlin Heidenberg: New York; 2010. [CrossRef] Uzal C, Çaloğlu M. Kanser etyolojisinde iyonizan radyasyonun yeri. Trakya Üniv Tıp Fak Derg 2002; 19:177-82. Günalp B. İyonize Radyasyonun biyolojik etkileri. Gülhane Askeri Tıp Akademisi ve Tıp Fakültesi Nükleer Tıp Anabilim Dalı, 2003.
  2. Özgüner F, Mollaoglu H. Manyetik alanın organizma üzerindeki biyolojik etkileri. Med J SDU 2006; 13: 38-41.
  3. Ertekin MV, Koc M, Karslioglu I, Sezen O, Taysi S, Bakan N. The effects of oral zinc sulphate during radiotherapy on antioxidant enzyme activities in patients with head and neck cancer: a prospective, randomized, placebo-controlled study. Int J Clin Pract 2004; 58: 662-8. [CrossRef] Pluquet O, North S, Richard MJ, Hainaut P. Activation of p53 by the cytoprotective aminothiol WR1065: DNA-damage-independent pathway and redox-dependent modulation of p53 DNA-binding activity. Biochem Pharmacol 2003; 65: 1129-37. [CrossRef] Yuhas MJ, Philips TL. Parmacokinetics and mechanisms of action of WR-2721 and other protective agents. Radioprotector and Anticarciogenesis. New York: Academic Press; 1982.p.639-53.
  4. Azza MM, Nadia MM, Sohair SM. Sativa seeds against Schistosoma mansoni different stages. Mem Inst Oswaldo Cruz 2005; 100: 205211. Salem ML. Immunomodulatory and immunotherapeutic proporties of the nigella sativa L seed. Int Immunopharmacol 2005; 5:1749-70. [CrossRef] Alves-Silva JM, Romane A, Efferth T, Salgueiro L. North African Medicinal Plants Traditionally Used in Cancer Therapy. Front Pharmacol 2017; 26: 383. [CrossRef] Negi P, Rathore C, Sharma G, Bhoop BS, Katare OP. Thymoquinone (TQ) a potential therapeutic molecule: Role of colloidal carriers in its effective delivery. Recent Pat Drug Deliv Formul 2018; 12: 3-22. [CrossRef] Farooqui Z, Shahid F, Khan AA, Khan F. Oral administration of Nigella sativa oil and thymoquinone attenuates long term cisplatin treatment induced toxicity and oxidative damage in rat kidney. Biomed Pharmacother 2017; 96: 912-23. [CrossRef] Mostofa AGM, Hossain MK, Basak D, Bin Sayeed MS. Thymoquinone as a Potential Adjuvant Therapy for Cancer Treatment: Evidence from Preclinical Studies. Front Pharmacol 2017 12; 8: 295. Kou B, Liu W, Zhao W, Duan P, Yang Y, Yi Q, et al. Thymoquinone inhibits epithelial-mesenchymal transition in prostate cancer cells by negatively regulating the TGF-β/Smad2/3 signaling pathway. Oncol Rep 2017; 38: 3592-8. [CrossRef] Williams CS, Mann M, DuBois RN. The role of c